nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0819	0.332	CbGbCtD
Rifaximin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0762	0.308	CbGbCtD
Rifaximin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.035	0.142	CbGbCtD
Rifaximin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0321	0.13	CbGbCtD
Rifaximin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0219	0.0885	CbGbCtD
Rifaximin—Pain—Vincristine—peripheral nervous system neoplasm	0.000566	0.000752	CcSEcCtD
Rifaximin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000752	CcSEcCtD
Rifaximin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000566	0.000752	CcSEcCtD
Rifaximin—Rash—Melphalan—peripheral nervous system neoplasm	0.000564	0.00075	CcSEcCtD
Rifaximin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000564	0.000749	CcSEcCtD
Rifaximin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000562	0.000746	CcSEcCtD
Rifaximin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00056	0.000743	CcSEcCtD
Rifaximin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000559	0.000742	CcSEcCtD
Rifaximin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000741	CcSEcCtD
Rifaximin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.00074	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000556	0.000738	CcSEcCtD
Rifaximin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000553	0.000734	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000732	CcSEcCtD
Rifaximin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000547	0.000727	CcSEcCtD
Rifaximin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000727	CcSEcCtD
Rifaximin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000546	0.000725	CcSEcCtD
Rifaximin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.000725	CcSEcCtD
Rifaximin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000722	CcSEcCtD
Rifaximin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000543	0.000722	CcSEcCtD
Rifaximin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000543	0.000721	CcSEcCtD
Rifaximin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000542	0.000719	CcSEcCtD
Rifaximin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000541	0.000718	CcSEcCtD
Rifaximin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000539	0.000715	CcSEcCtD
Rifaximin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000539	0.000715	CcSEcCtD
Rifaximin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000537	0.000713	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000534	0.000709	CcSEcCtD
Rifaximin—Infection—Etoposide—peripheral nervous system neoplasm	0.000533	0.000708	CcSEcCtD
Rifaximin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000707	CcSEcCtD
Rifaximin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000532	0.000706	CcSEcCtD
Rifaximin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000532	0.000706	CcSEcCtD
Rifaximin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000702	CcSEcCtD
Rifaximin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000699	CcSEcCtD
Rifaximin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000524	0.000695	CcSEcCtD
Rifaximin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000524	0.000695	CcSEcCtD
Rifaximin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000693	CcSEcCtD
Rifaximin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000521	0.000692	CcSEcCtD
Rifaximin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000519	0.000689	CcSEcCtD
Rifaximin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000687	CcSEcCtD
Rifaximin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000511	0.000679	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000677	CcSEcCtD
Rifaximin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000509	0.000676	CcSEcCtD
Rifaximin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000507	0.000674	CcSEcCtD
Rifaximin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000506	0.000673	CcSEcCtD
Rifaximin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000672	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000506	0.000671	CcSEcCtD
Rifaximin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000501	0.000666	CcSEcCtD
Rifaximin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000501	0.000665	CcSEcCtD
Rifaximin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000657	CcSEcCtD
Rifaximin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000657	CcSEcCtD
Rifaximin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000655	CcSEcCtD
Rifaximin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000654	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000653	CcSEcCtD
Rifaximin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.00065	CcSEcCtD
Rifaximin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000649	CcSEcCtD
Rifaximin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000488	0.000648	CcSEcCtD
Rifaximin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.000646	CcSEcCtD
Rifaximin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000641	CcSEcCtD
Rifaximin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000483	0.000641	CcSEcCtD
Rifaximin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000639	CcSEcCtD
Rifaximin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000635	CcSEcCtD
Rifaximin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000478	0.000635	CcSEcCtD
Rifaximin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000634	CcSEcCtD
Rifaximin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000475	0.000631	CcSEcCtD
Rifaximin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000474	0.00063	CcSEcCtD
Rifaximin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000626	CcSEcCtD
Rifaximin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000626	CcSEcCtD
Rifaximin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000471	0.000626	CcSEcCtD
Rifaximin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00047	0.000625	CcSEcCtD
Rifaximin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.000621	CcSEcCtD
Rifaximin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000466	0.000619	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000463	0.000615	CcSEcCtD
Rifaximin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000463	0.000615	CcSEcCtD
Rifaximin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000463	0.000614	CcSEcCtD
Rifaximin—Pain—Etoposide—peripheral nervous system neoplasm	0.000459	0.000609	CcSEcCtD
Rifaximin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000459	0.000609	CcSEcCtD
Rifaximin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000608	CcSEcCtD
Rifaximin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000608	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000604	CcSEcCtD
Rifaximin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000455	0.000604	CcSEcCtD
Rifaximin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000453	0.000602	CcSEcCtD
Rifaximin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.0006	CcSEcCtD
Rifaximin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000597	CcSEcCtD
Rifaximin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000593	CcSEcCtD
Rifaximin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000591	CcSEcCtD
Rifaximin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000591	CcSEcCtD
Rifaximin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000588	CcSEcCtD
Rifaximin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000442	0.000587	CcSEcCtD
Rifaximin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000586	CcSEcCtD
Rifaximin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00044	0.000585	CcSEcCtD
Rifaximin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000583	CcSEcCtD
Rifaximin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000439	0.000583	CcSEcCtD
Rifaximin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000438	0.000582	CcSEcCtD
Rifaximin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00058	CcSEcCtD
Rifaximin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000579	CcSEcCtD
Rifaximin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000579	CcSEcCtD
Rifaximin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000576	CcSEcCtD
Rifaximin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000575	CcSEcCtD
Rifaximin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000431	0.000573	CcSEcCtD
Rifaximin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.000572	CcSEcCtD
Rifaximin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000426	0.000566	CcSEcCtD
Rifaximin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000565	CcSEcCtD
Rifaximin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000564	CcSEcCtD
Rifaximin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000424	0.000563	CcSEcCtD
Rifaximin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000424	0.000563	CcSEcCtD
Rifaximin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000562	CcSEcCtD
Rifaximin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000559	CcSEcCtD
Rifaximin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000421	0.000559	CcSEcCtD
Rifaximin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00042	0.000558	CcSEcCtD
Rifaximin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000558	CcSEcCtD
Rifaximin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000555	CcSEcCtD
Rifaximin—Rash—Vincristine—peripheral nervous system neoplasm	0.000418	0.000555	CcSEcCtD
Rifaximin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000417	0.000554	CcSEcCtD
Rifaximin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000554	CcSEcCtD
Rifaximin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000553	CcSEcCtD
Rifaximin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000551	CcSEcCtD
Rifaximin—Headache—Vincristine—peripheral nervous system neoplasm	0.000415	0.000551	CcSEcCtD
Rifaximin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000547	CcSEcCtD
Rifaximin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.000542	CcSEcCtD
Rifaximin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000401	0.000532	CcSEcCtD
Rifaximin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000395	0.000525	CcSEcCtD
Rifaximin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000524	CcSEcCtD
Rifaximin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000523	CcSEcCtD
Rifaximin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000393	0.000522	CcSEcCtD
Rifaximin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000522	CcSEcCtD
Rifaximin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000522	CcSEcCtD
Rifaximin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.00052	CcSEcCtD
Rifaximin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000518	CcSEcCtD
Rifaximin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000516	CcSEcCtD
Rifaximin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000514	CcSEcCtD
Rifaximin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000512	CcSEcCtD
Rifaximin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000385	0.000511	CcSEcCtD
Rifaximin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00051	CcSEcCtD
Rifaximin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.00051	CcSEcCtD
Rifaximin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000507	CcSEcCtD
Rifaximin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00038	0.000504	CcSEcCtD
Rifaximin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000372	0.000495	CcSEcCtD
Rifaximin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000493	CcSEcCtD
Rifaximin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000369	0.00049	CcSEcCtD
Rifaximin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000369	0.00049	CcSEcCtD
Rifaximin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000489	CcSEcCtD
Rifaximin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000367	0.000488	CcSEcCtD
Rifaximin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000485	CcSEcCtD
Rifaximin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000483	CcSEcCtD
Rifaximin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000482	CcSEcCtD
Rifaximin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000473	CcSEcCtD
Rifaximin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000472	CcSEcCtD
Rifaximin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000355	0.000471	CcSEcCtD
Rifaximin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000471	CcSEcCtD
Rifaximin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000469	CcSEcCtD
Rifaximin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000348	0.000462	CcSEcCtD
Rifaximin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000456	CcSEcCtD
Rifaximin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000454	CcSEcCtD
Rifaximin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000341	0.000453	CcSEcCtD
Rifaximin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000453	CcSEcCtD
Rifaximin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000452	CcSEcCtD
Rifaximin—Rash—Etoposide—peripheral nervous system neoplasm	0.000338	0.000449	CcSEcCtD
Rifaximin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000338	0.000449	CcSEcCtD
Rifaximin—Headache—Etoposide—peripheral nervous system neoplasm	0.000336	0.000446	CcSEcCtD
Rifaximin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000446	CcSEcCtD
Rifaximin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000441	CcSEcCtD
Rifaximin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000331	0.00044	CcSEcCtD
Rifaximin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000439	CcSEcCtD
Rifaximin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000438	CcSEcCtD
Rifaximin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000435	CcSEcCtD
Rifaximin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00043	CcSEcCtD
Rifaximin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000427	CcSEcCtD
Rifaximin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000319	0.000423	CcSEcCtD
Rifaximin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.00042	CcSEcCtD
Rifaximin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000419	CcSEcCtD
Rifaximin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000417	CcSEcCtD
Rifaximin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000417	CcSEcCtD
Rifaximin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000417	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000414	CcSEcCtD
Rifaximin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000412	CcSEcCtD
Rifaximin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000408	CcSEcCtD
Rifaximin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000407	CcSEcCtD
Rifaximin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000407	CcSEcCtD
Rifaximin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000406	CcSEcCtD
Rifaximin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000403	CcSEcCtD
Rifaximin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000399	CcSEcCtD
Rifaximin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000398	CcSEcCtD
Rifaximin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000397	CcSEcCtD
Rifaximin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000395	CcSEcCtD
Rifaximin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000393	CcSEcCtD
Rifaximin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000392	CcSEcCtD
Rifaximin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000388	CcSEcCtD
Rifaximin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000386	CcSEcCtD
Rifaximin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000386	CcSEcCtD
Rifaximin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000386	CcSEcCtD
Rifaximin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000386	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000383	CcSEcCtD
Rifaximin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000381	CcSEcCtD
Rifaximin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000381	CcSEcCtD
Rifaximin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000377	CcSEcCtD
Rifaximin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Rifaximin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Rifaximin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00037	CcSEcCtD
Rifaximin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000367	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000364	CcSEcCtD
Rifaximin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000364	CcSEcCtD
Rifaximin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000362	CcSEcCtD
Rifaximin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000361	CcSEcCtD
Rifaximin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000359	CcSEcCtD
Rifaximin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000357	CcSEcCtD
Rifaximin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000356	CcSEcCtD
Rifaximin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000352	CcSEcCtD
Rifaximin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000347	CcSEcCtD
Rifaximin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Rifaximin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000344	CcSEcCtD
Rifaximin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000342	CcSEcCtD
Rifaximin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000342	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000337	CcSEcCtD
Rifaximin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000334	CcSEcCtD
Rifaximin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000329	CcSEcCtD
Rifaximin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000329	CcSEcCtD
Rifaximin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000327	CcSEcCtD
Rifaximin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000321	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000319	CcSEcCtD
Rifaximin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000319	CcSEcCtD
Rifaximin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000317	CcSEcCtD
Rifaximin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000316	CcSEcCtD
Rifaximin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000316	CcSEcCtD
Rifaximin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000316	CcSEcCtD
Rifaximin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000316	CcSEcCtD
Rifaximin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000305	CcSEcCtD
Rifaximin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000302	CcSEcCtD
Rifaximin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000294	CcSEcCtD
Rifaximin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000294	CcSEcCtD
Rifaximin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000292	CcSEcCtD
Rifaximin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000292	CcSEcCtD
Rifaximin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000287	CcSEcCtD
Rifaximin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000283	CcSEcCtD
Rifaximin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000273	CcSEcCtD
Rifaximin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000272	CcSEcCtD
Rifaximin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000265	CcSEcCtD
Rifaximin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000264	CcSEcCtD
Rifaximin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000261	CcSEcCtD
Rifaximin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000254	CcSEcCtD
Rifaximin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000253	CcSEcCtD
Rifaximin—Rash—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000252	CcSEcCtD
Rifaximin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000252	CcSEcCtD
Rifaximin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00025	CcSEcCtD
Rifaximin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000244	CcSEcCtD
Rifaximin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000237	CcSEcCtD
Rifaximin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000235	CcSEcCtD
Rifaximin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000233	CcSEcCtD
Rifaximin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000233	CcSEcCtD
Rifaximin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000232	CcSEcCtD
Rifaximin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00022	CcSEcCtD
